Asns - asparagine synthetase Gene
Species: Mus musculus
Summary
Predicted to enable asparagine synthase (glutamine-hydrolyzing) activity and identical protein binding activity. Predicted to be involved in several processes, including asparagine biosynthetic process; cellular response to glucose starvation; and positive regulation of mitotic cell cycle. Predicted to act upstream of or within cellular amino acid biosynthetic process and glutamine metabolic process. Predicted to be active in cytosol. Is expressed in several structures, including alimentary system; eye; genitourinary system; nervous system; and respiratory system. Orthologous to human ASNS (asparagine synthetase (glutamine-hydrolyzing)). [provided by Alliance of Genome Resources, Apr 2022]
Asns Products (6)
| mRNA | Protein | Name |
|---|---|---|
| NM_001410605.1 | NP_001397534.1 | asparagine synthetase [glutamine-hydrolyzing] isoform a |
| NM_001410606.1 | NP_001397535.1 | asparagine synthetase [glutamine-hydrolyzing] isoform a |
| NM_001410607.1 | NP_001397536.1 | asparagine synthetase [glutamine-hydrolyzing] isoform a |
| NM_001410608.1 | NP_001397537.1 | asparagine synthetase [glutamine-hydrolyzing] isoform a |
| NM_001410609.1 | NP_001397538.1 | asparagine synthetase [glutamine-hydrolyzing] isoform b |
| NM_012055.5 | NP_036185.1 | asparagine synthetase [glutamine-hydrolyzing] isoform a |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
asparagine synthetase [glutamine-hydrolyzing] |
|
Related Agents
- Approval
- Clinical Phase
- Pre-clinical Phase
Approval
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-132254 | Sacituzumab govitecan | Inhibitor | 99.13% | Unkown |
| HY-132254A | Sacituzumab govitecan (solution) | Inhibitor | 99.19% | Unkown |
| HY-N0667 | L-Asparagine | 99.78% | Unkown | |
| HY-W017443 | L-Asparagine monohydrate | 99.77% | Unkown | |
| HY-14874 | Topiroxostat | Inhibitor | 99.06% | Unkown |
| HY-123319 | Antofloxacin hydrochloride | Inhibitor | / | Unkown |
| HY-123319A | Antofloxacin | Inhibitor | / | Unkown |
Clinical Phase
| Cat. No. | Product Name |
Effect
|
Purity |
Phase |
|---|---|---|---|---|
| HY-103018 | Gusacitinib | Inhibitor | 99.63% | Phase 2 |
| HY-136579 | ASN007 | Inhibitor | 99.48% | Phase 1 |
| HY-160196 | HC-7366 | Inhibitor | 99.58% | Phase 1 |
| HY-164457 | ASN-001 | Inhibitor | / | Phase 1 |
Pre-clinical Phase
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-128946 | CL2A-SN-38 | 99.97% | Unkown | |
| HY-128923 | SKF-34288 hydrochloride | Inhibitor | 98.61% | Unkown |
| HY-W002327 | Fmoc-Asn(Trt)-OH | 99.96% | Unkown | |
| HY-136626 | Z-Ala-Ala-Asn-AMC | 99.28% | Unkown | |
| HY-108625 | SHA 68 | Antagonist | 99.84% | Unkown |
| HY-112205A | RR-11a analog | Inhibitor | 99.12% | Unkown |
| HY-164668 | ADC Control Human IgG1-SN-38 | 97.53% | Unkown | |
| HY-P4385 | (Asn10,Leu11,D-Trp12)-pTH-Related Protein (7-34) amide (human, mouse, rat) | Antagonist | 99.77% | Unkown |
| HY-N0667S2 | L-Asparagine-15N2 monohydrate | 99.95% | Unkown | |
| HY-139147 | iHCK-37 | Inhibitor | 99.52% | Unkown |
| HY-175282 | ASX-173 | 98.47% | Unkown | |
| HY-114174 | Fmoc-Ala-Glu-Asn-Lys-NH2 | 99.55% | Unkown | |
| HY-136579A | ASN007 benzenesulfonate | Inhibitor | 99.72% | Unkown |
| HY-W010378 | D-Asparagine | 98.0% | Unkown | |
| HY-156586 | Egalognastat | Inhibitor | 99.03% | Unkown |
| HY-N9446 | H-Asn(glcnac-beta-D)-OH | 98.65% | Unkown | |
| HY-P1341 | OXA(17-33) | 97.48% | Unkown | |
| HY-P1043A | NGR peptide Trifluoroacetate | 98.91% | Unkown | |
| HY-N0667S3 | L-Asparagine-13C4 monohydrate | 98.9% | Unkown | |
| HY-W009085 | Fmoc-Asn-OH | 99.19% | Unkown | |
| HY-W017443S | L-Asparagine-13C4,15N2 monohydrate | 98.0% | Unkown | |
| HY-111323 | ASN06917370 | 99.23% | Unkown | |
| HY-128111 | ASN02563583 | Activator | 99.21% | Unkown |
| HY-B1803A | Tracazolate hydrochloride | Modulator | 99.24% | Unkown |
| HY-E70068 | Endo-β-N-acetylglucosaminidase (Endo S) | / | Unkown | |
| HY-N0667S5 | L-Asparagine-d3 hydrate | 99.64% | Unkown | |
| HY-113667 | ASN04885796 | Activator | 99.40% | Unkown |
| HY-148393 | G0 N-glycan-Asn | 99.95% | Unkown | |
| HY-P11200 | γ-Glu-Asn | 98.12% | Unkown | |
| HY-W013330 | 3′-Deoxyguanosine | 97.0% | Unkown | |
| HY-P4279 | Ovalbumin (154-159) | Inhibitor | 99.18% | Unkown |
| HY-125028 | Hck-IN-1 | Inhibitor | 98.10% | Unkown |
| HY-150242A | Cbz-Ala-Ala-Asn TFA | 99.54% | Unkown | |
| HY-150579 | Keap1-Nrf2-IN-13 | Inhibitor | 96.77% | Unkown |
| HY-162238 | OSM-S-106 | Inhibitor | 99.34% | Unkown |
| HY-150787 | BMS-986339 | 99.74% | Unkown | |
| HY-128128 | ASN04421891 | Modulator | 99.00% | Unkown |
| HY-131092A | H-Asn-Arg-OH diTFA | 99.83% | Unkown | |
| HY-175282A | (2S,3R,4S)-ASX-173 | Control | 99.29% | Unkown |
| HY-P10485 | Glp-Asn-Pro-AMC | 99.26% | Unkown | |
| HY-P1809A | Velmupressin acetate | Agonist | 99.47% | Unkown |
| HY-P1962 | β-Secretase inhibitor | Inhibitor | 98.06% | Unkown |
| HY-W010378R | D-Asparagine (Standard) | 99.90% | Unkown | |
| HY-129360A | Ala-Ala-Asn-PAB TFA | / | Unkown | |
| HY-141464 | Fmoc-L-Asn(beta-D-GlcNAc(Ac)3)-OH | 95.03% | Unkown | |
| HY-156314 | ASN 07115873 | Inhibitor | 98.76% | Unkown |
| HY-172473 | DSPE-PEG2000-NGR | 95.0% | Unkown | |
| HY-176977 | Exatecan-mpGly-Asn-Asn-(βAla) | 96.74% | Unkown | |
| HY-180467 | Neu5Ac-2Galβ1-3Glc-oxazoline-(2)Me | / | Unkown | |
| HY-180467A | Neu5Ac-2Galβ1-3Glc-oxazoline-(2)Me sodium | / | Unkown | |
| HY-78162 | cis-3-Hydroxyproline | Substrate | 95.0% | Unkown |
| HY-N0667S | L-Asparagine-13C4,15N2,d8 | 99% | Unkown | |
| HY-N0667S1 | L-Asparagine-15N2,d8 | 99.94% | Unkown | |
| HY-P3882 | Fmoc-Ala-Glu-Gln-Lys-NH2 | 99.26% | Unkown | |
| HY-W008233 | Z-Asn-OH | 98.76% | Unkown | |
| HY-W017443S1 | L-Asparagine-amide-15N monohydrate | 99.80% | Unkown | |
| HY-148389 | Disialo-Asn | 98.04% | Unkown | |
| HY-W017443S2 | L-Asparagine-13C4,15N2,d3 monohydrate | 99.90% | Unkown | |
| HY-W142294 | Ac-D-Asn-OH | / | Unkown | |
| HY-P1809 | Velmupressin | Agonist | / | Unkown |
| HY-P1810 | c(Bua-Cpa-Thi-Val-Asn-Cys)-Pro-Agm | Agonist | / | Unkown |
| HY-103018A | Gusacitinib hydrochloride | Inhibitor | / | Unkown |
| HY-P1043 | NGR peptide | 99.73% | Unkown | |
| HY-103018S | Gusacitinib-d4 | / | Unkown | |
| HY-113761 | ASN03576800 | Inhibitor | 99.61% | Unkown |
| HY-122179 | NUCC-555 | Antagonist | / | Unkown |
| HY-128947 | CL2 Linker | / | Unkown | |
| HY-129360 | Ala-Ala-Asn-PAB | / | Unkown | |
| HY-129361 | Fmoc-Ala-Ala-Asn-PABC-PNP | / | Unkown | |
| HY-130933 | Fmoc-Ala-Ala-Asn(Trt)-OH | 99.80% | Unkown | |
| HY-131463 | ASN-1377642 | Antagonist | / | Unkown |
| HY-136733 | Ac-DNLD-CHO | Inhibitor | / | Unkown |
| HY-139245 | MC-Ala-Ala-Asn-PAB | / | Unkown | |
| HY-141149 | Fmoc-PEG4-Ala-Ala-Asn-PAB | / | Unkown | |
| HY-141150 | Azido-PEG5-Ala-Ala-Asn-PAB | / | Unkown | |
| HY-141151 | Fmoc-PEG3-Ala-Ala-Asn(Trt)-PAB | / | Unkown | |
| HY-144628 | Fmoc-Asn-Pro-Val-PABC-PNP | 99.34% | Unkown | |
| HY-144629 | Asn-Pro-Val-PABC-MMAE TFA | / | Unkown | |
| HY-144630 | diSPhMC-Asn-Pro-Val-PABC-MMAE | / | Unkown | |
| HY-148031 | MC-Ala-Ala-Asn-PAB-PNP | / | Unkown | |
| HY-148392 | Neu5Gcα(2-6) N-Glycan-Asn | / | Unkown | |
| HY-149360 | P-gb-IN-1 | Inhibitor | / | Unkown |
| HY-149825 | MTHFD2-IN-1 | Inhibitor | / | Unkown |
| HY-149826 | MTHFD2-IN-2 | Inhibitor | / | Unkown |
| HY-149827 | MTHFD2-IN-3 | Inhibitor | / | Unkown |
| HY-149828 | MTHFD2-IN-4 | Inhibitor | / | Unkown |
| HY-149828A | MTHFD2-IN-4 sodium | Inhibitor | / | Unkown |
| HY-151146 | (1R,3S)-THCCA-Asn | Inhibitor | / | Unkown |
| HY-172472 | DSPE-PEG1000-NGR | / | Unkown | |
| HY-172473A | DSPE-PEG3400-NGR | / | Unkown | |
| HY-172474 | DSPE-PEG5000-NGR | / | Unkown | |
| HY-174223 | α-Glucosidase-IN-90 | Inhibitor | / | Unkown |
| HY-183362 | Antileishmanial agent-42 | Inhibitor | / | Unkown |
| HY-185461 | Mc-Asn-Asn-E104 | Agonist | / | Unkown |
| HY-185462 | Mc-Asn-Asn | / | Unkown | |
| HY-E71264 | β-Acetylglucosaminidase 18A, Bacteroides thetaiotaomicron | / | Unkown | |
| HY-N0667S4 | L-Asparagine-4-13C monohydrate | / | Unkown | |
| HY-N0667S7 | L-Asparagine-13C4,15N2 | / | Unkown | |
| HY-P11408 | [D-Cys6,Asn7,D-Ala11,Cys14]-Bombesin (6-14) | Agonist | / | Unkown |
| HY-P11620 | H-Asn-Pro-Glu-Tyr(PO3H2)-OH | / | Unkown | |
| HY-P1610 | Asudemotide | Inducer | / | Unkown |
| HY-P2212 | (Asn1,Val5)-Angiotensin II | / | Unkown | |
| HY-P2397 | Fmoc-Asn(Trt)-Thr(psi(Me,Me)pro)-OH | / | Unkown | |
| HY-P2401 | Fmoc-Asn(Trt)-Ser(psi(Me,Me)pro)-OH | / | Unkown | |
| HY-P3220 | [D-Asn5]-Oxytocin | Activator | / | Unkown |
| HY-P3615 | [Asn18] Endothelin-1 (swine, human) | Agonist | / | Unkown |
| HY-P3716 | H(-Asn-Pro-Asn-Ala)2-OH | / | Unkown | |
| HY-P4019 | Ac-Ser-Gln-Asn-Tyr-Pro-Val-Val-NH2 | / | Unkown | |
| HY-P4407 | (D-Asn28)-Exenatide | Control | / | Unkown |
| HY-P4919 | Mca-SEVNLDAEFK(Dnp) | / | Unkown | |
| HY-P5415 | DABCYL-GABA-Ser-Gln-Asn-Tyr-Pro-Ile-Val-Gln-EDANS | / | Unkown | |
| HY-RS01098 | ASNS Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W017443S3 | L-Asparagine-15N2,d3 monohydrate | / | Unkown | |
| HY-W017443S4 | L-Asparagine-1,2,3,4-13C4 monohydrate | / | Unkown | |
| HY-W091365 | Boc-Asn(Xan)-OH | / | Unkown | |
| HY-W845197 | L-Asparagine-15N2 | / | Unkown | |
| HY-118731 | TNK-6123 | Activator | / | Unkown |
| HY-129286 | ASN 05397535 | / | Unkown | |
| HY-131092 | H-Asn-Arg-OH | / | Unkown | |
| HY-141152 | Azido-PEG4-Ala-Ala-Asn(Trt)-PAB | / | Unkown | |
| HY-141153 | Fmoc-PEG3-Ala-Ala-Asn(Trt)-PAB-PNP | / | Unkown | |
| HY-151829 | Fmoc-L-Asn(EDA-N3)-OH | / | Unkown | |
| HY-157338 | NHS-Ala-Ala-Asn-active metabolite | Inhibitor | / | Unkown |
| HY-RS19117 | Asns Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS25607 | Asns Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W002327S | Fmoc-Asn(Trt)-OH-13C4,15N2 | 96.9% | Unkown | |
| HY-W173361 | CBP/p300-IN-24 | Inhibitor | / | Unkown |
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-P992184 | Anti-5T4 scFv-Fc Antibody | / | Unkown | |
| HY-P991497 | ASN-500 | Inhibitor | / | Unkown |